Intranasal Abuse Potential, Pharmacokinetics, and Safety of Once-Daily, Single-Entity, Extended-Release Hydrocodone (HYD) in Recreational Opioid Users

Objectives. A once-daily, extended-release hydrocodone bitartrate tablet with abuse-deterrent properties (Hysingla ER® [HYD]) is available for the treatment of chronic pain in appropriate patients. This study evaluated the intranasal abuse potential and pharmacokinetics of HYD coarse and fine partic...

Descripción completa

Detalles Bibliográficos
Autores principales: Harris, Stephen C., Cipriano, Alessandra, Colucci, Salvatore V., Kapil, Ram P., Geoffroy, Pierre, Hopyan, Talar, Levy-Cooperman, Naama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
GENERAL SECTION
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984427/
https://www.ncbi.nlm.nih.gov/pubmed/26814240
http://dx.doi.org/10.1093/pm/pnv004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4984427/
https://www.ncbi.nlm.nih.gov/pubmed/26814240
http://dx.doi.org/10.1093/pm/pnv004

Ejemplares similares